Ledger.Open graph →
SEC Form D · filed August 28, 2020

Prelude Therapeutics Inc

Offering
$50.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Wilmington, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Mardi C. Dier · Wilmington, DEDirectorVictor Sandor · Wilmington, DEDirectorPaul Friedman · New York, NYDirectorAndrew C. Combs · Wilmington, DEExecBrian C. Piper · Wilmington, DEExecKrishna Vaddi · Chadds Ford, PAExec · DirectorChristopher C. Pierce · Wilmington, DEExecPeggy C. Scherle · Wilmington, DEExecBrian C. Piper · Wilmington, DEExecDavid C. Mauro · Wilmington, DEExecDeborah C. Morosini · Wilmington, DEExecKrishna Vaddi · Chadds Ford, PAExec · DirectorPaul Friedman · San Francisco, CADirectorPeggy C. Scherle · Wilmington, DEExecMardi C. Dier · Wilmington, DEDirectorDeborah C. Morosini · Wilmington, DEExecKelvin Neu · San Francisco, CADirectorDavid Bonita · Montreal, Quebec, CanadaDirectorChristopher C. Pierce · Wilmington, DEExecKelvin Neu · Newark, DEDirectorAndrew C. Combs · Wilmington, DEExecDavid C. Mauro · Wilmington, DEExecDavid Bonita · New York, NYDirectorVictor Sandor · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗